Who
Sridhar Kosaraju
Director
Company insider
Files Form 4 as: Director, 10x Genomics; Director, Nevro; President, Penumbra.
In numbers
- Trades disclosed
- 175
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $17.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 15 Nov 2016
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,829 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —15,357 at $0.00 | filing |
| 3 Apr 2025filed 3 Apr 2025 | Nevro | SEC FORM 4 Code D | —46,575 | filing |
| 31 Dec 2024filed 2 Jan 2025 | Nevro | SEC FORM 4 Code A | —4,233 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | Nevro | SEC FORM 4 Code A | —2,817 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | Nevro | SEC FORM 4 Code A | —1,870 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —8,649 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | Nevro | SEC FORM 4 Code A | —19,169 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | Nevro | SEC FORM 4 Code A | —1,090 at $0.00 | filing |
| 31 Dec 2023filed 3 Jan 2024 | Nevro | SEC FORM 4 Code A | —731 at $0.00 | filing |
| 30 Sep 2023filed 3 Oct 2023 | Nevro | SEC FORM 4 Code A | —819 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | Nevro | SEC FORM 4 Code A | —619 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —4,661 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —1,865 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | Nevro | SEC FORM 4 Code A | —6,754 at $0.00 | filing |
| 31 Mar 2023filed 4 Apr 2023 | Nevro | SEC FORM 4 Code A | —435 at $0.00 | filing |
| 30 Dec 2022filed 4 Jan 2023 | Nevro | SEC FORM 4 Code A | —397 at $0.00 | filing |
| 30 Sep 2022filed 4 Oct 2022 | Nevro | SEC FORM 4 Code A | —337 at $0.00 | filing |
| 14 Sep 2022filed 16 Sep 2022 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
News
7,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 202610x Genomics and Fred Hutch partner on cancer technologiesTXG · pharmaceutical-business-review.com · 8 Oct 2026
0 headlines in the last 90 days name Sridhar Kosaraju; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.